Cambridge Nutritional Sciences plc Stock price
Equities
ODX
GB00B1VCP282
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.5 GBX | -4.11% | +4.48% | +45.83% |
Jan. 29 | Cambridge Nutritional Sciences hires first operations chief | AN |
Jan. 29 | Cambridge Nutritional Sciences plc Announces Appointment of James Cooper as Operations Director | CI |
Sales 2024 * | 9M 11.34M | Sales 2025 * | - | Capitalization | 8.69M 10.95M |
---|---|---|---|---|---|
Net income 2024 * | -1M -1.26M | Net income 2025 * | - | EV / Sales 2024 * | 0.5 x |
Net cash position 2024 * | 4.2M 5.29M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.3
x | P/E ratio 2025 * |
-
| Employees | 91 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.83% |
Latest transcript on Cambridge Nutritional Sciences plc
1 day | -4.11% | ||
1 week | +4.48% | ||
Current month | +32.08% | ||
1 month | +32.08% | ||
3 months | +45.83% | ||
6 months | +75.00% | ||
Current year | +45.83% |
Managers | Title | Age | Since |
---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Douglas
CHM | Chairman | 65 | 21-02-10 |
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
Jeremy Millard
BRD | Director/Board Member | 53 | 19-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 3.5 | -4.11% | 211 495 |
24-03-27 | 3.65 | +4.29% | 2,331,944 |
24-03-26 | 3.5 | +6.06% | 1,007,828 |
24-03-25 | 3.3 | 0.00% | 44,211 |
24-03-22 | 3.3 | -1.49% | 201,932 |
Delayed Quote London S.E., March 28, 2024 at 06:05 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+45.83% | 10.97M | |
-4.69% | 8.1B | |
-5.04% | 5.13B | |
+2.96% | 4.72B | |
-34.08% | 4.4B | |
-2.48% | 4.14B | |
+15.50% | 2.82B | |
+2.82% | 2.55B | |
+11.81% | 1.92B | |
-1.77% | 1.65B |